23andMe Holding Co. (ME)
0.61
0.00 (0.61%)
At close: Mar 28, 2025, 3:59 PM
23andMe Revenue Breakdown
| Period Ending | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Consumer Services Revenue | 43.59M | 19.65M | 42.9M | 2.9M | 3.1M | n/a | 31.3M | 43.4M | 59.3M | 17.05M | 34M | 39.9M | 47.85M |
| Consumer Services Revenue Growth | +121.82% | -54.19% | +1379.24% | -6.45% | n/a | -100.00% | -27.88% | -26.81% | +247.82% | -49.86% | -14.79% | -16.61% | n/a |
| Research Services Revenue | 26.7M | 97.07M | 1.85M | 48.66M | 22.5M | 212.64M | n/a | 10M | 24.5M | 83.51M | 46.04M | 44.49M | 50.6M |
| Research Services Revenue Growth | -72.49% | +5149.86% | -96.20% | +116.26% | -89.42% | n/a | n/a | -59.18% | -70.66% | +81.39% | +3.49% | -12.08% | n/a |
| Service Revenue | 38.51M | 88.25M | 7.82M | 9.06M | n/a | n/a | n/a | n/a | n/a | 11.53M | 7.67M | 55.2M | n/a |
| Service Revenue Growth | -56.36% | +1028.29% | -13.63% | n/a | n/a | n/a | n/a | n/a | n/a | +50.32% | -86.10% | n/a | n/a |
| Health Care, Other Revenue | 6.42M | 17.69M | 35.08M | 39.6M | n/a | n/a | n/a | n/a | n/a | 71.98M | 38.37M | n/a | n/a |
| Health Care, Other Revenue Growth | -63.69% | -49.57% | -11.43% | n/a | n/a | n/a | n/a | n/a | n/a | +87.60% | n/a | n/a | n/a |
| PGS Revenue | 37.17M | 93.07M | 44.75M | 50M | n/a | n/a | n/a | n/a | n/a | 100.56M | 56.89M | n/a | n/a |
| PGS Revenue Growth | -60.06% | +107.98% | -10.50% | n/a | n/a | n/a | n/a | n/a | n/a | +76.76% | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
|---|---|---|---|
| Canada Revenue | 10.56M | 13.58M | 14.29M |
| Canada Revenue Growth | -22.21% | -4.98% | n/a |
| Other Regions Revenue | 4.64M | 5.64M | 6.68M |
| Other Regions Revenue Growth | -17.77% | -15.59% | n/a |
| United States Revenue | 180.15M | 217.24M | 192.44M |
| United States Revenue Growth | -17.07% | +12.89% | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 43.35M | 39.01M | 46.54M | 39.23M | 57.18M | 40.98M | 70.76M | 48.54M | 70.58M | 50.45M | 63.08M | 66.19M | 71.43M | 29.85M | 28.02M | 66.01M | 28.85M | 22.64M | 24.85M |
| Selling, General, and Administrative Revenue Growth | +11.13% | -16.18% | +18.65% | -31.40% | +39.54% | -42.09% | +45.79% | -31.23% | +39.90% | -20.02% | -4.70% | -7.35% | +139.29% | +6.56% | -57.56% | +128.83% | +27.39% | -8.86% | n/a |
| Research and Development Revenue | 20.22M | 41.04M | 42.76M | 46.72M | 41.72M | 54.59M | 62.33M | 60.72M | 57.27M | 52.6M | 52.01M | 50.32M | 50.3M | 44.52M | 44.23M | 45.6M | 41.68M | 38.2M | 34.37M |
| Research and Development Revenue Growth | -50.74% | -4.01% | -8.49% | +11.99% | -23.57% | -12.42% | +2.65% | +6.02% | +8.88% | +1.13% | +3.35% | +0.05% | +12.97% | +0.66% | -2.99% | +9.38% | +9.11% | +11.16% | n/a |
| Sales and Marketing Revenue | 12.67M | 10.11M | 8.61M | 10.5M | 21.61M | 11.03M | 15.32M | 21.78M | 39.88M | 16.27M | 33.43M | 29.35M | 35.77M | 13.59M | 15.42M | 22.58M | 8.76M | 8.33M | 10.65M |
| Sales and Marketing Revenue Growth | +25.31% | +17.46% | -17.98% | -51.43% | +95.89% | -27.97% | -29.66% | -45.39% | +145.08% | -51.33% | +13.91% | -17.93% | +163.21% | -11.87% | -31.72% | +157.77% | +5.19% | -21.83% | n/a |